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Abstract
The immune system kills bacteria by the formation of lytic
membrane attack complexes (MACs), triggered when complement
enzymes cleave C5. At present, it is not understood how the MAC
perturbs the composite cell envelope of Gram-negative bacteria.
Here, we show that the role of C5 convertase enzymes in MAC
assembly extends beyond the cleavage of C5 into the MAC precursor
C5b. Although purified MAC complexes generated from preassem-
bled C5b6 perforate artificial lipid membranes and mammalian cells,
these components lack bactericidal activity. In order to permeabilize
both the bacterial outer and inner membrane and thus kill a
bacterium, MACs need to be assembled locally by the C5 convertase
enzymes. Our data indicate that C5b6 rapidly loses the capacity to
form bactericidal pores; therefore, bacterial killing requires both
in situ conversion of C5 and immediate insertion of C5b67 into the
membrane. Using flow cytometry and atomic force microscopy, we
show that local assembly of C5b6 at the bacterial surface is required
for the efficient insertion of MAC pores into bacterial membranes.
These studies provide basic molecular insights into MAC assembly
and bacterial killing by the immune system.
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Introduction
Membrane attack complex (MAC) formation is an evolutionarily
conserved immune mechanism to kill bacteria and altered self-cells.
It results from activation of the complement cascade (present in
blood and most bodily fluids; Kang et al, 2009; Ricklin et al, 2010),
when newly formed C5b6 complexes bind C7, C8, and multiple C9
molecules to build hetero-oligomeric MAC pores into target cell
membranes. The MAC has an essential role in human immune
protection against Gram-negative bacteria; this is evident from
recurrent infections in patients lacking MAC activity due to genetic
deficiencies (Ram et al, 2010; Turley et al, 2015) or due to treatment
with complement-inhibitory drugs (Konar & Granoff, 2017;
McNamara et al, 2017; Ricklin et al, 2017). Since MAC-dependent
cell lysis can be specifically triggered via antibodies, this killing
mechanism is also exploited for therapeutic development of antibod-
ies that target cancer cells or drug-resistant bacterial infections
(Szija´rto´ et al, 2015; de Jong et al, 2016). Despite its crucial role in
immunity, it is currently not understood how the MAC kills bacteria.
In vivo, the MAC is generated via an enzymatic chain reaction on
the target cell surface (Ricklin et al, 2010; Berends et al, 2014).
Following recognition of a foreign cell via antibodies or pattern
recognition molecules, proteins of the complement system (Ricklin
et al, 2010; Ugurlar et al, 2018) rapidly organize into a proteolytic
cascade that eventually results in cleavage—by C5 convertase
enzymes—of precursor C5 into the anaphylatoxin C5a and C5b
(Gros et al, 2008; Ricklin et al, 2010); C5b initiates the assembly of
the MAC (C5b-9; Hadders et al, 2012; Serna et al, 2016; Sharp et al,
2016; Bayly-Jones et al, 2017). Nascent C5b by itself is labile, but
forms stable C5b6 complexes by rapid association with C6 (Cooper
& Mu¨ller-Eberhard, 1970; Hadders et al, 2012). Next, C5b6
complexes bind C7, which changes conformation to expose a
hydrophobic domain that renders the complex lipophilic (Preissner
et al, 1985). Once C5b-7 is bound to the target membrane, its
assembly with C8 and 18 copies of C9 results in the formation of the
MAC (Bayly-Jones et al, 2017; preprint: Parsons et al, 2018). Recent
in vitro structural studies (Serna et al, 2016; Sharp et al, 2016;
Menny et al, 2018; preprint: Parsons et al, 2018) have revealed
detailed information on how MAC proteins form toroid-shaped
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pores with an inner diameter of 10 nm, spanning a single phospho-
lipid (bilayer) membrane. Despite these structural insights, it
remains unclear how these pores can kill Gram-negative bacteria.
Since the cytoplasmic membrane of Gram-negative bacteria is physi-
cally protected by a peptidoglycan layer and an outer membrane
(Silhavy et al, 2010), it is unclear how MAC pores, with a trans-
membrane region of < 10 nm (Serna et al, 2016; Sharp et al, 2016),
can perturb this composite cell wall. Furthermore, it is not known if
MAC can perturb both membranes and if other serum components,
such as the peptidoglycan-degrading enzyme lysozyme (Wright &
Levine, 1981), are required to kill a bacterium.
In this paper, we demonstrate that although the purified MAC
components (C5b-9) form pores in artificial lipid membranes (Serna
et al, 2016; Sharp et al, 2016), they require additional complement
components to be bactericidal. Specifically, we find that MAC-
dependent killing critically depends on the prior labeling of the
bacterial surface with C5 convertase enzymes. Using novel
membrane perturbation analyses and atomic force microscopy, we
here show that in situ cleavage of C5 by convertases at the microbial
surface and immediate insertion of newly formed C5b67 complexes
into the membrane is essential for the MAC to perturb both bacterial
membranes and to be bactericidal. Our data highlight a critical role
for complement activation mechanisms at the cell surface to induce
bacterial killing.
Results
MAC in serum perturbs both the outer and inner membrane of
Gram-negative bacteria
To better understand bacterial killing by the MAC, we developed a flow
cytometry-based approach that can distinguish between outer and
inner membrane perforation in Gram-negative bacteria following expo-
sure to human serum, which contains all complement proteins and has
potent bactericidal activity against Gram-negative bacteria (Berends
et al, 2014). Outer membrane integrity was monitored by measuring
release of mCherry from the periplasmic space of genetically
engineered E. coli MG1655 cells (Fig 1A and B). Inner membrane
integrity was monitored by detecting release of cytosolic Green Fluores-
cent Protein (GFP) or by the influx of small molecule DNA dyes
(Lebaron et al, 1998). Upon exposure of these cells to human serum,
the periplasmic mCherry signal decreased in the entire population,
indicating permeabilization of the outer membrane (Figs 1C and EV1A).
Although cytosolic GFP signals remained constant, human serum
induced effective passage of small DNA dyes (Figs 1C and EV1A).
By carefully titrating concentrations of serum (and thus comple-
ment components), we found that the influx of DNA dyes, but not
mCherry release, strongly correlated with bacterial cell death
(Figs 1C and EV1B). Also, in two wild-type E. coli strains and a clin-
ical isolate of Stenotrophomonas maltophilia (S. maltophilia), we
observed that serum-induced inner membrane disruption correlated
with bacterial killing (Fig 1D and E). Both inner membrane disrup-
tion and killing by human serum fully relied on the presence of
MAC components but not on the peptidoglycan-degrading lysozyme
(Figs 1D and E, and EV1C). Taken together, these data suggest that
MAC-mediated disruption of the inner membrane is an essential
requirement for killing of Gram-negative bacteria in human serum.
Purified MAC components lack the bactericidal activity of serum
To assess how the MAC can damage both membranes, we used
purified MAC components instead of serum. Although nascent C5b
is unstable, rapid association with C6 (Cooper & Mu¨ller-Eberhard,
1970; Hadders et al, 2012) leads to formation of stable C5b6
complexes that initiate the assembly of the MAC (C5b6-9; Hadders
et al, 2012; Serna et al, 2016; Sharp et al, 2016; Bayly-Jones et al,
2017; Fig 2A). Such stable C5b6 complexes can be generated by
activating C5 and C6 on activating surfaces (in C7-deficient serum)
and subsequently purify released C5b6 from the supernatant (van
den Berg, 2000). Upon incubation with C7, C8, and C9, such puri-
fied, preassembled C5b6 complexes can form MAC pores in vari-
ous cell types. This protocol was recently used for structure
determination of the MAC following its formation in liposomes
(Serna et al, 2016; Menny et al, 2018). In concordance with
literature, we also observed that preassembled C5b6 complexes
can associate with proteins C7, C8, and C9 to assemble lytic MAC
pores (henceforward denoted as C5b6MACs) in liposomes
(Fig EV2A; Sharp et al, 2016) and mammalian erythrocytes
[human (Fig 2B) and rabbit (Fig EV2B (Lachmann & Thompson,
1970))].
However, when preassembled C5b6 triggers MAC formation on
bacteria, these pores lack the bactericidal activity of human serum
(Fig 2C), even at protein concentrations exceeding those in blood
(Fig EV2C). Although C5b6MAC is not bactericidal, it decreased
mCherry signals in the entire population, indicating permeabiliza-
tion of the outer membrane (Fig 2D). While C5b6MAC pores perturb
the bacterial outer membrane, they—unlike serum—lack the ability
to damage the inner membrane of Gram-negative bacteria (Fig 2D
and E). We conclude that C5b6MAC lacks bactericidal activity in spite
of its effectiveness in perturbing the outer membrane.
Reconstituting bactericidal MAC assembly via surface-bound
C5 convertases
To identify which additional factors in serum are needed to form
bactericidal MAC pores, we next attempted to more closely mimic
in vivo MAC assembly via cell-bound C5 convertases (Figs 3A and
EV3A; Berends et al, 2014). In serum, antibodies or pattern recogni-
tion molecules specifically drive the deposition of C5 convertases
onto the target cell surface (Gros et al, 2008; Ricklin et al, 2010;
Berends et al, 2014). This occurs in a step-wise manner (Fig EV3A):
firstly, all three recognition pathways deposit C3 convertase
enzymes that cleave protein C3 into C3b, which covalently attaches
to the cell surface via a reactive thioester. At high densities of
surface-bound C3b, C3 convertases associate with deposited C3b to
form a C5 convertase. Although their surface-specific nature and
covalent attachment make it technically challenging to generate C5
convertases in a purified manner, we here show that pre-incubation
of bacteria with human serum devoid of C5 (DC5 serum) results in
functionally active (mainly alternative pathway) C5 convertases on
the bacterial surface (Fig EV3B–D).
When such convertase-labeled bacteria were next washed and
then incubated with uncleaved C5 and components C6, C7, C8, and
C9, we found that the resulting MAC pores (denoted as Conv-MAC)
effectively killed bacteria (Fig 3B) in a C5 dose-dependent manner
(Fig 3C). As is the case in vivo, C5 convertases here were essential
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Figure 1. MAC in serum perturbs both the outer and inner membrane of Gram-negative bacteria.
A Schematic representation of engineered perimCherry/cytoGFP E. coli cells that express mCherry in the periplasmic space (between the outer and inner membrane)
and GFP in the cytosol.
B Structured illumination microscopy image of perimCherry/cytoGFP E. coli confirming localization of mCherry (red) in the periplasm and GFP (green) in the cytosol.
Scale bar = 3 lm.
C Outer membrane damage (mCherry intensity) and inner membrane damage (% Sytox positive) of perimCherry/cytoGFP E. coli bacteria exposed to (different
concentrations of) human serum. Inner membrane damage correlates with killing (samples where bacteria are killed are indicated with gray shadings and a cross,
see CFU data in Fig EV1B).
D, E (D) Serum-induced inner membrane damage (% Sytox positive) and (E) killing (CFU/ml) of different Gram-negative strains depends on MAC components C5 and C8,
but not on lysozyme (10% serum). Dotted line represents the detection limit of the assay.
Data information: The cfu/ml (E) and Sytox measurements (D) of “Buffer”, “Serum”, “DC5”, “DC8”, “Dlysozym”, and “C5b6MAC” were all generated from the same
experiment. (C–E) Data represent mean  SD of 3 independent experiments. (D, E) Statistical analysis was done using a ratio paired two-tailed t-test and displayed only
when significant as *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, or ****P ≤ 0.0001.
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for bacterial killing, since no killing was observed when bacteria
were pre-incubated with convertase-negative serum (heat-inacti-
vated DC5 serum (Fig 3C), which lacks the capacity to deposit C3b
(Fig EV3C) and to convert C5 (Fig EV3D). In addition, bacterial
killing was fully inhibited when convertase formation was blocked
by compstatin (Sahu et al, 1996; Fig 3D), which specifically inhibits
surface deposition of C3b (Fig EV3C) and formation of functional
C5 convertases (Fig EV3D). The here observed bacterial killing was
MAC-specific, as it required the presence of C5-C9 to be fully effec-
tive (Fig 3D). In the presence of C5-C8 alone (no C9), bacterial
killing was much less effective but not insignificant (Fig 3D),
supporting previous reports on bactericidal effects of C5b-8 in the
absence of C9 (O’Hara et al, 2001). Similar to these results based on
alternative pathway C5 convertases, specific labeling of bacteria
with classical/lectin pathway C5 convertases also led to bacterial
cell death upon incubation with C5-C9 (Fig 3E). Altogether, these
data demonstrate that purified MAC can kill bacteria when its
assembly is driven by cell-bound C5 convertases.
MAC assembly via surface-bound C5 convertases leads to inner
membrane damage
Given that MAC assembly via surface-bound C5 convertases results
in bacterial cell death, we assessed whether it also results in inner
membrane damage. To study this, perimCherry/cytoGFP bacteria were
labeled with C5 convertases of the alternative pathway, washed,
and next incubated with components C5-C9, as described above. In
concordance with its bactericidal activity, we found that convertase-
driven MAC assembly perturbed both the outer and inner
membrane of perimCherry/cytoGFP E. coli, in a C5 dose-dependent
manner (Fig 4A). In accordance with the killing data in Fig 3C and
D, we observed that inhibition of C5 convertase formation via heat
inactivation or by adding compstatin prevented MAC-mediated
inner membrane damage (Fig 4B). Furthermore, C5 convertase-
generated MAC pores (Conv-MAC) also induced inner membrane
damage in wild-type E. coli and S. maltophilia strains (Fig 4C).
Consistent with the flow cytometry results, confocal microscopy
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Figure 2. Purified MAC components lack the bactericidal activity of serum.
A Purified MAC (denoted as C5b6MAC) can be formed by mixing preassembled C5b6 complexes with C7, C8, and C9.
B Lysis of human erythrocytes after exposure to a concentration range of preassembled C5b6 in the presence of 100 nM C7. After washing, erythrocytes were exposed
to 20 nM C8 and 100 nM C9 for 30 min after which the OD405 nm of the supernatant was measured.
C Bacterial viability of three Gram-negative strains after exposure to buffer, 10% human serum or C5b6MAC. Buffer and serum conditions are the same as Fig 1E.
D Permeabilization of the outer, but not inner membrane of perimCherry/cytoGFP E. coli cells exposed to C5b6MAC (different concentrations of C5b6 with fixed
concentrations of C7-C9).
E Inner membrane damage of three Gram-negative strains exposed to buffer, 10% serum or C5b6MAC. Buffer and serum conditions are the same as Fig 1D.
Data information: The cfu/ml (C) and Sytox measurements (E) of “Buffer”, “Serum”, “DC5”, “DC8”, “Dlysozym”, and “C5b6MAC” were all generated from the same
experiment. (B–E) Data represent mean  SD of 3 independent experiments. (C, E) Statistical analysis was done using a ratio paired two-tailed t-test and displayed only
when significant as *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, or ****P ≤ 0.0001. Normal concentrations of MAC proteins in 100% human serum are  375 nM C5, 550 nM C6,
600 nM C7, 350 nM C8, and 900 nM C9.
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further confirmed that the combination of surface-bound C5 conver-
tases and MAC induces inner membrane damage in bacteria
(Fig 4D). In conclusion, when the MAC is assembled from purified
C5-C9 by surface-bound convertases, these pores trigger inner
membrane damage and subsequent bacterial killing.
Local assembly of C5b6 by surface-bound C5 convertases is
required for bacterial killing
Having established a protocol to generate bactericidal MACs under
semi-purified conditions, we next investigated the difference
between the non-bactericidal MACs formed by preassembled C5b6
and fully functional, convertase-generated MACs formed from C5
and C6. To this end, we labeled bacteria with C5 convertases as
described above and subsequently generated MACs by incubation
with preassembled C5b6 and C7-C9 (Conv-C5b6MAC) or by incuba-
tion with uncleaved C5 and C6 and C7-C9 (Conv-MAC; Fig 5A). In
this direct comparison, only the Conv-MAC killed bacteria (Fig 5B)
and triggered inner membrane damage (Fig 5C), whereas both
Conv-C5b6MAC and Conv-MAC triggered outer membrane damage
(Fig 5D). These results indicate that the role of C5 convertases
extends beyond the cleavage of C5 into C5a and C5b: In particular,
the C5 convertase should be present on the cell surface and
locally assemble C5b6 to generate bactericidal pores. Interestingly,
and fully consistent with the lytic function of C5b6MAC on lipo-
somes (Fig EV2A) and mammalian erythrocytes (Figs 2B and
EV2B), local assembly of C5b6 by surface-bound C5 convertases
was not essential to kill human cells (Fig EV4; note that this
experiment was performed on human (HAP1) cells deficient in
complement regulators CD46, CD55, CD59 (Thielen et al, 2018)
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Figure 3. Reconstituting bactericidal MAC assembly via surface-bound C5 convertases.
A Schematic overview for Conv-MAC formation. Bacteria were labeled with C5 convertases by pre-incubation with C5-deficient serum (Fig EV3). Following a washing
step (@), convertase-labeled bacteria were incubated with uncleaved C5, C6, C7, C8, and C9 (termed “Conv-MAC”).
B Bacterial viability of convertase-labeled bacterial strains exposed to buffer (Conv) or C5-C9 (Conv-MAC).
C Bacterial viability of convertase-labeled E. coli MG1655 exposed to a concentration range of C5 in the presence of 100 nM C6, 100 nM C7, 20 nM C8, and 100 nM C9.
“Ctrl” indicates bacteria that are pretreated with heat-inactivated DC5 serum. Dotted line represents the detection limit of the assay.
D Bacterial viability of convertase-labeled E. coli MG1655 exposed to C5-C9 or conditions lacking one MAC component. As an extra control, convertase formation was
blocked during DC5 serum incubation by adding 5 lM compstatin.
E Bacterial viability of E. coli MG1655 exposed to FB depleted serum in the presence of 20 lg/ml OmCI (to deposit C4b and C3b without Bb). After washing, bacteria
were exposed to C5-C9 in the presence or absence of C1 and C2 (to generate classical pathway C5 convertases, C4b2aC3b).
Data information: (B–E) Data represent mean  SD of 3 independent experiments. (B, D, E) Statistical analysis was done using a ratio paired two-tailed t-test and
displayed only when significant as *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, or ****P ≤ 0.0001.
ª 2019 The Authors The EMBO Journal e99852 | 2019 5 of 17
Dani AC Heesterbeek et al How complement kills bacteria The EMBO Journal
Published online: January 14, 2019 
that, if present, would prevent any C3b or MAC deposition on the
cell surface).
Given that C5b6MAC (Fig 2D) and Conv-C5b6MAC (Fig 5D) pores
both perturb the bacterial outer membrane, but not the inner
membrane, the local assembly of C5b6 via surface-bound C5 conver-
tases seems particularly important to generate pores that can damage
the complete, composite cell envelope of a Gram-negative bacterium.
C5b6 rapidly loses the capacity to form bactericidal pores
To understand why local formation of C5b6 is required, we next
focused on the early assembly steps of the MAC, involving C5b, C6,
and C7. In the experiments described above, bactericidal pores
(Conv-MAC) were generated when convertase-labeled were simulta-
neously incubated with C5-C9 (Fig 4) [or when directly compared to
C5b6MAC, with C5-C7 and after washing C8 and C9 (Fig 5)]. Next,
we studied whether we could introduce a washing step between the
formation of C5b6 and the addition of C7. Interestingly, we found
that washing after C5b6 assembly did not affect the formation of
MAC pores that permeabilize the outer membrane (Fig 6A), but
strongly blocked formation of MAC pores that trigger inner
membrane damage (Fig 6B). In contrast, when C5b6 was formed in
the presence of C7, we observed that washing did not affect the abil-
ity of MACs to permeabilize the outer and inner membrane (Fig 6A
and B). This suggests that locally assembled C5b6 requires immedi-
ate insertion into the membrane via C7. In a different experimental
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Figure 4. MAC assembly via surface-bound C5 convertases leads to inner membrane damage.
A Outer membrane damage (mCherry intensity) and inner membrane damage (% Sytox positive) of convertase-labeled perimCherry/cytoGFP E. coli cells incubated with a
concentration range of C5 and fixed concentrations of C6-C9.
B Inner membrane damage of perimCherry/cytoGFP E. coli exposed to a concentration range of DC5 serum and, after washing, to C5-C9. As controls, bacteria were
incubated with heat-inactivated DC5 serum or 5 lM compstatin was added to the DC5 serum to block C3b deposition.
C Inner membrane damage of three different convertase-labeled bacteria exposed to buffer (Conv) or C5-C9 (Conv-MAC).
D Confocal microscopy images of convertase-labeled perimCherry/cytoGFP E. coli exposed to buffer (Conv) or C5-C9 (Conv-MAC). Unlabeled bacteria exposed to 1% serum
served as control. Green = GFP, red = To-pro-3 DNA dye. Scale bars = 3 lm.
Data information: (A–C) Data represent mean  SD of 3 independent experiments. (C) Statistical analysis was done using a ratio paired two-tailed t-test and displayed
only when significant as *P ≤ 0.05 or **P ≤ 0.01.
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set-up, we did not wash the bacteria following incubation with C5
and C6, but instead blocked the generation of new C5b6 molecules
using Eculizumab, a clinically approved C5 inhibitor that blocks
recognition and cleavage of C5 by the convertase (Rother et al,
2007). We observed that Eculizumab blocked formation of bacterici-
dal MAC pores when it was added after C5b6 assembly but before the
addition of C7 (Fig 6A and B). In contrast, Eculizumab could not
prevent bactericidal MAC formation when added after the addition of
C5, C6, and C7 (Fig 6A and B). These data show that although C5b6
complexes that are formed in the absence of C7 can form pores that
damage the outer membrane, these complexes rapidly lose the ability
to form bactericidal pores. In contrast, when newly generated C5b6
can immediately bind C7 at the bacterial surface, these complexes
can form a bactericidal MAC. Together with the fact that purified,
preassembled C5b6 complexes lack the capacity to form bactericidal
MAC pores, these data indicate a previously unrecognized short-lived
ability of C5b6 to induce bacterial killing and further explains why
local assembly of C5b6 by C5 convertases on the target surface is so
crucial for bacterial killing via the MAC.
Inner membrane damage is driven by MAC assembly at the
outer membrane
Next, we investigated how bactericidal MAC pores perturb the bacte-
rial cell envelope. Specifically, we analyzed whether inner membrane
damage results from MAC formation in the outer or inner membrane.
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Figure 5. Local assembly of C5b6 by surface-bound C5 convertases is required for killing.
A Schematic overview of MAC assembly on convertase-labeled bacteria by C5b6 that is locally generated by incubation with C5 and C6 (top) or by preassembled C5b6
(bottom).
B Bacterial viability of convertase-labeled E. coli MG1655 exposed to Buffer (Conv), preassembled C5b6 (Conv + C5b6MAC) or a mixture of C5 and C6 (Conv-MAC), in
the presence of C7, C8, and C9. Dotted line represents the detection limit of the assay.
C, D (C) Inner membrane damage (% Sytox positive) and (D) outer membrane damage (mCherry) of convertase-labeled perimCherry/cytoGFP E. coli exposed to a
concentration range of preassembled C5b6 or a mixture of C5 and C6, in the presence of 100 nM C7. After washing, bacteria were exposed to 20 nM C8 and
100 nM C9.
Data information: (B–D) Data represent mean  SD of 3 independent experiments. (B) Statistical analysis was done using a ratio paired two-tailed t-test and displayed
only when significant as **P ≤ 0.01.
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We performed step-wise assembly of MAC pores on convertase-
labeled bacteria and assessed damage of both membranes at each
step. First of all, we observed that the labeling of bacteria with
convertases, and subsequent assembly of C5b-7 (in absence of C8
and C9), did not affect permeability of either membrane (Fig 7A).
Convertase-driven formation of C5b-8 allowed some passage of small
molecule DNA dyes (Sytox, Fig 7A) but not of proteins (mCherry;
Fig 7A). As shown before, the formation of a full MAC pore (C5b-9)
is required to effectively permeabilize both membranes (Fig 7A). To
further disentangle the effect of MAC formation on the outer and
inner membrane, we introduced a washing step after the incubation
with C5-C8. At this stage, the outer membrane did not show signifi-
cant permeability for proteins (mCherry, Fig 7A), leading us to
conclude that all remaining C5b-8 must be bound to the outer
membrane surface only. Intriguingly, subsequent incubation of
(washed) bacteria with C9 led to both outer and inner membrane
permeabilization (Fig 7A and B). This suggests that assembly of
bactericidal MAC pores takes place in the bacterial outer membrane
only and that destabilization of the inner membrane is of a different
nature than outer membrane permeabilization, not requiring the step-
wise assembly of new convertases or C5b-9 pores.
Local formation of C5b6 is required for efficient insertion of MAC
pores into the outer membrane
Since the above experiments indicate that formation of bactericidal
MAC pores mainly takes place on the outer membrane, we more
closely analyzed pore formation on the bacterial surface. First, we
quantified the total number of MAC assemblies on convertase-labeled
bacteria using flow cytometry (Fig 8A). We compared C9-Cy3 incor-
poration on convertase-labeled bacteria when MAC formation was
triggered via uncleaved C5 and C6 (Conv-MAC) or preassembled
C5b6 (Conv-C5b6MAC; solid lines in Fig 8A). The dose–response
curves indicate that MAC formation was up to ~3-fold more efficient
with locally formed C5b6 (Conv-MAC), although the difference was
absent at higher (100 nM) concentrations of C5b6 (Fig 8A). This is in
apparent contradiction with the vast differences in inner membrane
damage between Conv-MAC and Conv-C5b6MAC at these concentra-
tions (Fig 5C). Since these differences could not be explained by a dif-
ferent distribution of Conv-C5b6MAC and Conv-MAC pores at the cell
surface either (Fig 8B), we next tested how well Conv-C5b6MAC or
Conv-MAC pores are inserted into the bacterial membrane by
measuring their resistance to trypsin after MAC formation. Trypsin is
commonly used as a shaving method to determine surface exposure
of membrane-associated proteins (Moskovich & Fishelson, 2007;
Besingi & Clark, 2015). While trypsin treatment effectively reduced
the amount of C9-Cy3 incorporation for the preparations with
preassembled C5b6, it had no effect on MAC pores generated via C5
and C6 (Fig 8A). Altogether, these data indicate that the C5b6MACs
are less well attached to and therefore presumably less well inserted
into the bacterial membrane than Conv-MACs.
Next, we visualized MAC assembly in the outer membrane using
atomic force microscopy (AFM) on live bacteria. Immobilized,
untreated E. coli cells appeared as smooth rods (Fig 8C), which at
BA
Co
nv
-M
AC
 (n
o C
5)
Co
nv
-M
AC
Co
nv
+C
5-6
@C
7-9
Co
nv
+C
5-C
7@
C8
-9
Co
nv
+C
5-6
-E
cu
-C
7-9
Co
nv
+C
5-C
7-E
cu
-C
8-9
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
R
el
at
iv
e 
m
C
he
rry
 s
ig
na
l
Co
nv
-M
AC
 (n
o C
5)
Co
nv
-M
AC
Co
nv
+C
5-6
@C
7-9
Co
nv
+C
5-C
7@
C8
-9
Co
nv
+C
5-6
-E
cu
-C
7-9
Co
nv
+C
5-C
7-E
cu
-C
8-9
0
20
40
60
80
100
120
%
 P
os
iti
ve
 (S
yt
ox
)
*
*
Figure 6. C5b6 rapidly loses the capacity to form bactericidal pores.
A, B Step-wise assembly of MAC on convertase-labeled bacteria. Convertase-labeled bacteria were incubated with C5/C6 or C5/C6/C7 for 15 min, and subsequently
washed (@) or treated with 10 lg/ml Eculizumab (Ecu). Then, the remaining MAC components (C7-9 for C5/C6 or C8-9 for C5/C6/C7, respectively) were added to
the incubation mixture. In the control conditions (Conv-MAC), the remaining MAC components were added to the incubation mixture without washing or adding
an inhibitor. (A) Outer membrane damage (mCherry) and (B) inner membrane damage (% Sytox positive) were determined.
Data information: (A-B) Data represent mean  SD of 3 independent experiments. Statistical analysis was done using a ratio paired two-tailed t-test in which the test
conditions were compared to Conv-MAC and displayed only when significant as *P ≤ 0.05.
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high resolution showed densely packed, ~7-nm-wide porins, charac-
teristic of the bacterial outer membrane (Yamashita et al, 2012). By
contrast, following exposure of convertase-labeled bacteria to C5-C9
(Conv-MAC), the bacterial surface was covered with nanometer-
scale protrusions that at higher resolution appeared as 10  2 nm
high and 17  2 nm (peak to peak) wide pores, including—depend-
ing on AFM resolution—signatures of a C5b stalk extending
upwards from the pore (Fig 8C). These dimensions and appearance
are consistent with cryo-EM maps of MACs built up from preassem-
bled C5b6 on liposomes (Serna et al, 2016; Sharp et al, 2016). At
the surface of the immobilized, convertase-labeled bacteria, Conv-
MAC pores were further accentuated in the phase image (see Materi-
als and Methods), which provides an alternative means to differenti-
ate MAC pores from the underlying bacterial surface since it is
sensitive to the local material properties (Figs 8D and EV5A).
However, when MACs were formed from preassembled C5b6 on
convertase-labeled bacteria (Conv-C5b6MAC), it became extremely
challenging to discern pore structures at the bacterial surface
(Figs 8D and EV5B and C). This is consistent with previous AFM
experiments on related pore-forming proteins (Leung et al, 2014,
2017), in which inserted pores were readily detected on supported
lipid bilayers, but mobile, non-inserted pores were harder to resolve
due to the invasiveness of the AFM measurement and/or insufficient
temporal resolution. Hence, the trypsin shaving and AFM results
could be explained by inefficient insertion of Conv-C5b6MACs into
the membrane, implying that local assembly of C5b6 by surface-
bound convertases is essential for priming the efficient insertion of
MAC pores into bacterial membranes.
Finally, to further validate this explanation, we more closely
analyzed the efficiency by which Conv-C5b6MAC and Conv-MAC
pores damage the bacterial outer membrane. At high (0.3 nM) C8
concentrations, it appeared that Conv-C5b6MAC and Conv-MAC
pores are equally efficient in inducing leakage of mCherry through
the outer membrane (Fig EV5D), consistent with the findings in
Fig 5D. However, by carefully titrating the concentration of C8, we
observed that less pores (> 100-fold) are needed to induce maxi-
mum mCherry leakage in the conditions of locally assembled MAC
(Conv-MAC) compared to preassembled Conv-C5b6MAC (Fig EV5D).
Together with the trypsin shaving and AFM results, these data indi-
cate that local assembly of MAC pores triggers more efficient
membrane insertion and subsequently more effective damage to the
bacterial outer membrane. Future experiments are required to deter-
mine whether subsequent destabilization of the inner membrane
(Fig EV5E) results directly from a more extensively damaged outer
membrane or whether other mechanisms are at play to kill the cell.
Discussion
Although recent in vitro structural studies (Dudkina et al, 2016;
Serna et al, 2016; Sharp et al, 2016; Menny et al, 2018) have signifi-
cantly advanced our understanding of MAC formation in liposomes,
it is still not understood how these pores can damage the composite
envelope of Gram-negative bacteria. Here, we reveal that the assem-
bly and insertion of MAC pores into bacterial membranes differ from
liposomes and erythrocytes. While MAC pores generated from
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Figure 7. Inner membrane damage is driven by MAC assembly at the outer membrane.
A Outer and inner membrane damage of convertase-labeled bacteria exposed to different combinations of MAC components. “@” indicates a washing step.
B Outer and inner membrane damage of convertase-labeled bacteria exposed to C5-C8 and after washing, to a concentration range of C9.
Data information: Data represent mean  SD of 3 independent experiments. (A) Statistical analysis was done using a one-way ANOVA and displayed only when
significant as **P ≤ 0.01 or ****P ≤ 0.0001.
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B Convertase-labeled perimCherry/cytoGFP bacteria (Green) exposed to C5b6MAC or Conv-MAC. Conditions were similar to those in (A); however, C9-Cy5 was used to
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C, D Atomic force microscopy analysis of E. coli BL21 and MG1655 immobilized using the Poly-L-Lysine protocol. (C) Entire bacteria and high-resolution comparisons of
untreated and convertase-labeled E. coli BL21 exposed to C5-C9 (Conv-MAC) for 10 min. Scale bars: 800 nm (left) and 30 nm (right). Height scales: 1 lm (left),
8 nm (top right), 22 nm (bottom right). Width of magnification boxes: 42 nm, height scales: 8 nm (top) and 13 nm (bottom). Arrows highlight E. coli porin
structures; an asterisk highlights the C5b-7 stalk. Height profiles (bottom) are shown for the white dashed lines in the images. (D) Atomic force microscopy (height
and phase images) of convertase-labeled E. coli MG1655 exposed to a mixture of C5 and C6 (Conv-MAC) or preassembled C5b6 (Conv + C5b6MAC), in the presence of
C7, C8, C9, FB, and FD. Images were generated in the same experiment. Scale bars: 50 nm. Height scales: 15 nm. This figure and three other replicates are included
in Fig EV5B and C.
Data information: (A) Data represent mean  SD of 3 independent experiments.
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preassembled C5b6 can efficiently perforate single membrane parti-
cles, these MACs lack bactericidal activity. In order to kill a Gram-
negative bacterium, MACs need to be assembled locally by cell-
bound C5 convertase enzymes. Our data indicate that both the
in situ conversion of C5 by surface-bound convertases and immedi-
ate association of C5b with C6 and C7 are needed to guide proper
insertion of bactericidal MAC pores.
Our data imply that the C5b6 complex has a hitherto unrecog-
nized limitation in its ability to induce bacterial killing. The purified
C5b6 complex used in this study was generated by cleaving C5 in
the presence of C6, but in the absence of C7, on an activating
surface. Subsequently, the released C5b6 complexes were purified
from the solution (van den Berg, 2000). Numerous reports have
shown that these “preassembled” C5b6 complexes can efficiently
form MAC pores in eukaryotic membranes (Iida et al, 1991) and
liposomes (Michaels et al, 1976; Hu et al, 1981; Serna et al, 2016;
Sharp et al, 2016; Menny et al, 2018; preprint: Parsons et al, 2018).
We here found that the same preassembled C5b6 complexes lack the
capacity to generate MACs that kill bacteria. In contrast, C5b6 that is
formed locally by surface-bound C5 convertases efficiently forms
bactericidal MAC pores. The fact that locally assembled C5b6 rapidly
loses the ability to form bactericidal pores (Fig 6) suggests that C5b6
somehow becomes inactivated. Although the exact molecular mech-
anism for C5b6 inactivation is yet unknown, we here propose
several possible explanations. First, cleavage of C5 by C5 conver-
tases (hypothetical model in Fig 9A) results in a major conforma-
tional change in which the C5d domain of C5 (colored dark green)
translocates away from its original position. It is long known that
newly formed C5b is hydrophobic and therefore unstable in solution
(DiScipio et al, 1983); the rapid association with C6 (within
~2.5 min; Cooper & Mu¨ller-Eberhard, 1970; Shin et al, 1971) is
needed to form stable C5b6 complexes. We wonder whether local
cleavage of C5 would allow these hydrophobic sites of C5b to
directly bind to membranes (Al Salihi et al, 1988). Alternatively, we
speculate that locally assembled C5b may have more flexibility to
properly guide the localized insertion of following MAC components
into the bacterial membrane. The position of C5d in Fig 9A is based
on structures of preassembled C5b6 (Aleshin et al, 2012; Hadders
et al, 2012). However, the exact position of C5d in locally assembled
C5b may be different. Although the nature of the conformational
change from C5 to C5b is similar to that observed in conversion of
the highly homologous C3 into C3b (Janssen et al, 2006; Aleshin
et al, 2012), C5d translocation is less pronounced than C3d (Fig 9B).
Since the C5d domain is bound to a flexible arm, we speculate that
the functional differences between locally assembled C5b6 and
preassembled C5b6 could be due to more conformational flexibility
of C5b during local assembly (Fig 9C). These hypotheses seem in
contrast with a recent manuscript by Menny et al (2018) showing
that the core of C5b remains largely unchanged during MAC assem-
bly in liposomal membranes. However, since Menny et al used
preassembled C5b6 to generate MAC pores, the C5b6 structure
within these pores may differ from that of convertase-generated
C5b6 on a bacterial surface. Potential structural differences in locally
assembled C5b6 may be crucial to stably insert pores into bacterial
(outer) membranes that have a very heterogenous lipid composition
and varying lengths of lipopolysaccharide (LPS; Silhavy et al, 2010).
Interestingly, Menny et al also describe how C6 undergoes marked
domain rearrangements upon integration into the MAC. In contrast
to its conformation in preassembled C5b6 in solution, C6 in
membrane-inserted MAC pores has transmembrane hairpin regions
inserted into the membrane. The authors suggest that binding of C7
is needed to induce this structural change in C6 (Menny et al, 2018).
Potentially, such structural changes in C6 occur less efficient on
bacterial membranes, but are enhanced upon local C5b6 assembly,
immediate binding of C7 and insertion into the membrane. In addi-
tion, a direct and stable interaction between the C5 convertase and
C5b6 may be needed to maintain a different conformation of C5b6
that is lost upon release of C5b6 from the surface. Although it has
been postulated that C5b6 remains bound to the C5 convertase
(Morgan et al, 2016), it is currently difficult to assess such
complexes because of limited tools to study the multi-component C5
convertase enzymes that have a surface-specific conformation
(Rawal & Pangburn, 2001). Please note that the structural models of
(a subunit of the) C5 convertase enzyme bound to C5, C5b, and
C5b6 (Fig 9A, B, CI and CII) are not experimentally proven. Further-
more, the fact that such interactions are likely very transient
(washing abrogates C5b6 activity; Fig 6) will further complicate
demonstrating the existence of such intermediary complexes.
Finally, different forms of MAC assemblies may exist as has been
observed in liposomes, such as open versus closed pores (Menny
et al, 2018) or clustered pores (Sharp et al, 2016). Potentially, the
local generation of MAC pores by surface-bound C5 convertases
may influence the structure or clustering of pores on bacterial
membranes. Nevertheless, the here-proposed models do not exclude
other scenarios of C5b6 inactivation and further studies are needed
to determine what causes the rapid inactivation of C5b6.
In all, our data imply that the natural assembly of MAC via
surface-specific complement activation mechanisms is essential to
induce bacterial killing. Our findings that (high concentrations of)
preassembled C5b6 can trigger MAC-mediated perforation of
mammalian cells could be relevant for future studies on comple-
ment-mediated human diseases, where the MAC attacks the body’s
own cells. Some studies suggest that C5b6 can be released from acti-
vating surfaces (erroneously recognized host cell or bacterium) and
associate with neighboring host cells, thereby causing unwanted
“bystander” lysis (Podack & Tschopp, 1984). The information that
bacterial and human cells have different sensitivities for “released”
C5b6 may guide the development of complement inhibitors that
specifically block bystander lysis by released C5b6 without affecting
the assembly of bactericidal MAC pores.
Finally, our data also shed new light on the strongly debated
mechanism of bacterial killing via the MAC. The potent bacteriolytic
activity of serum was recognized in 1895 by Jules Bordet who
discovered complement as a potent system that allows antibodies to
directly kill bacteria (Schmalstieg & Goldman, 2009). However, the
exact mechanism of MAC-mediated bacterial killing has been
strongly debated (Bhakdi et al, 1987; Dankert & Esser, 1987; Taylor,
1992; Berends et al, 2014; Morgan et al, 2017). The fact that we
now have tools to form bactericidal MAC pores in a purified manner
will allow mechanistic studies to unravel how bactericidal MACs
damage the bacterial cell envelope. The data with step-wise MAC
formation (Fig 7) rule out the idea that formation of convertases
and/or C5b-9 underneath the outer membrane is required to make
pores in the inner membrane. Washing experiments show that
convertase-mediated MAC assembly mainly takes place on the outer
membrane. Up till the formation of C5b-8, we did not observe
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extensive damage to both membranes. Addition of C9 was required
to efficiently perturb the outer and inner membrane. This leaves us
with two potential hypotheses for bactericidal effects at the inner
membrane. First, MAC pores in the outer membrane could allow C9
to go through the pores and reach the inner membrane (as was
suggested earlier; Wang et al, 2000; Dankert & Esser, 1987). Given
that peptidoglycan has a pore-size distribution of 4–16 nm (Turner
et al, 2013), C9 (61 kDa) might be able to reach the inner
membrane where it may have cytotoxic effects (Berends et al,
2014). This would mean that pores formed in the inner membrane
(by C9) are different from the pores formed in the outer membrane
(C5b-9). However, since we observed no GFP leakage from the cyto-
plasm of E. coli upon exposure to the MAC (Fig EV1A), it seems less
likely that large pores are formed in the inner membrane. Second,
inner membrane damage may directly result from MAC-dependent
damage of the outer membrane. The fact that we measure influx of
DNA dyes does not necessarily mean that large pores are formed in
the inner membrane. Others have reported that extensive outer
membrane stress by itself may cause destabilization of the inner
membrane and passage of DNA dyes (Lebaron et al, 1998). Outer
membrane degradation may disrupt protein connections between
the outer and inner membrane that influence envelope stability
A B
C
Figure 9. Structural model for C5b6 assembly by C5 convertases.
A Hypothetical model for C5 cleavage by the alternative pathway C5 convertase. The AP C5 convertase is a multimeric complex between a dimeric C3 convertase
enzyme (comprised of surface-bound non-catalytic C3b in complex with protease Bb), together with additional surface-bound C3b molecules (not depicted here),
which are required to strengthen the affinity for C5. Hypothetical model of C3bBb (surface representation, C3b in gray, Bb in orange) bound to substrate C5 (light
green, C5d domain in dark green). C3bBb is derived from the dimeric C3bBb-SCIN complex (PDB 2WIN; Rooijakkers et al, 2009), and C5 is modeled based on
superposition of the CVF-C5 complex (PDB 3PVM; Laursen et al, 2011) on the C3b molecule from C3bBb. The right panel shows C3bBb bound to C5b (light green, C5d
in dark green). The structure of C5b is derived from the structure of the C5b6 complex (PDB 4A5W; Hadders et al, 2012) and superimposed on C5 from the model in
the left panel.
B Superposition of C5b with the C5d domain in the pC5b6 (dark green) and C3b-like (light blue) orientation. The C3b-like conformation of C5d was generated based on
superposition of the C5d structure (extracted from the pC5b6 structure, PDB 4A5W) on the C3d domain of the second C3b subunit from the dimeric C3bBb-SCIN
structure (PDB 2WIN).
C Hypothetical structural models for C5b6 assembly by convertases. (I) Model of pC5b6 bound to C3bBb, as in (A, right). (II) Model of pC5b6, with C5d-C6 superimposed
on C5d in the C3b-like orientation, as in (B). Note that this orientation allows C6 to extend further toward the membrane relative to the convertase. (III) Model in
which C5b6 has dissociated from C3bBb, but adopted the orientation shown in (II). All structural models and superpositions were generated using UCSF Chimera
(Pettersen et al, 2004).
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(Silhavy et al, 2010) or bacteria may turn on self-death machinery
in response to outer membrane stress, for example via the produc-
tion of regulatory RNAs (Konovalova et al, 2016). Exposing a bacte-
rial knockout library to the MAC may reveal whether bacterial
factors and active processes are involved in triggering OM-mediated
IM damage. This hypothesis would be consistent with the idea that
local assembly of the MAC is required to more efficiently perforate
the outer membrane and thereby indirectly cause inner membrane
damage. Since the outer membrane is a major permeability barrier
for most antibiotics, the mechanisms by which complement disrupts
Gram-negative cell envelopes may hold information crucial for
development of antimicrobial strategies against drug-resistant Gram-
negative bacteria (Laxminarayan et al, 2013).
Materials and Methods
Serum, reagents, and bacterial strains
Normal human serum and heat-inactivated serum were obtained
from healthy volunteers as previously described (Berends et al,
2013). Sera depleted of complement factors and complement factors
C5b6, C7, and C8 were obtained from Complement Technology.
His-tagged C5, C6, C9, FB, and FD were expressed in and purified
from HEK293E cells (U-Protein Express). Lysozyme-depleted serum
was prepared as described below. PerimCherry/cytoGFP E. coli was
prepared by transforming a pPerimCh plasmid into E. coli MG1655.
pPerimCh was modified from plasmid pFCcGi containing a constitu-
tively expressed mCherry and a L-arabinose inducible GFP (kindly
provided by Sophie Helaine). A pelB leader was added in front of
the mCherry sequence to direct mCherry to the periplasmic space.
Gram-negative isolate S. maltophilia 566954.1 was obtained from
the diagnostic Medical Microbiology department of the University
Medical Center Utrecht. OmCI was produced in HEK293E cells and
purified as previously described (Nunn et al, 2005). Eculizumab
was kindly provided by Frank Beurskens (Genmab, Utrecht, The
Netherlands). Normal concentrations of MAC proteins in 100%
human serum are:  375 nM C5, 550 nM C6, 600 nM C7, 350 nM
C8, and 900 nM C9. Hybridoma cells producing MoAb bH6 to C3b
were kindly provided by Peter Garred (University of Copenhagen)
and Tom Eirik Mollnes (University of Oslo). Antibodies were puri-
fied as previously described (Garred et al, 1988). Purified antibod-
ies were labeled with Alexa Fluor 488 reactive molecules
(ThermoFisher) following the supplier’s protocol.
Preparation of lysozyme-depleted serum
The sequence of lysozyme inhibitor LprI of M. tuberculosis without
signal peptide was synthesized (IDT; Sethi et al, 2016). The
sequence was cloned into a modified, N-terminal His-tag followed
by a TEV cleavage site, pRSETB vector (Thermofisher) digested with
BamHI/NotI using Gibson assembly (NEB). The protein of interest
was expressed in BL21(DE3; Thermofisher) by adding 1 mM IPTG.
LprI was isolated under denaturing conditions using a Histrap column
(GE Healthcare). For lysozyme depletion, a Histrap column was
charged with CoCl2 and loaded with 1.1 mg His-tagged LprI. The
protein was covalently linked to the column by adding 0.05% H2O2
in PBS for 1 h at RT. After washing with PBS, 4 ml of human pooled
serum in the presence of 10 mM EDTA was loaded on the column.
To the flow-through, containing lysozyme-depleted serum, 10 mM
CaCl2 and 10 mM MgCl2 were added. Lysozyme-depleted serum
was analyzed for complement activity by performing a CH50
(Fig EV1C). Complement activity was comparable to serum before
lysozyme depletion. Successful depletion was demonstrated using a
lysozyme ELISA (Abcam), which showed over 99% depletion of
lysozyme.
Hemolytic and liposome assay
Rabbit erythrocytes (1 × 108/ml) or liposomes (Wako CH50 Auto
kit) were incubated with buffer or purified MAC components
for 30 min, non-shaking at 37°C. 10 nM C5b6, 20 nM C7, 20 nM
C8, and 100 nM C9 were used. Incubations were done in
Veronal + 2.5 mM MgCl2 and 0.5 mM CaCl2, VBS++. As positive
controls, erythrocytes were incubated with MQ, liposomes with
0.05% PBS-Tween. After incubations, erythrocytes were spun down
and absorbance of the supernatant at OD405 nm was measured. The
percentage of lysed rabbit erythrocytes was calculated by comparing
the OD405 nm of the test sample with the OD405 nm of the Milli-Q
control sample, which was set at 100% lysis. NADH production as a
result of G6PDH leakage from liposomes was determined by measur-
ing the absorbance at OD340 nm. Human erythrocytes were
collected from freshly drawn blood, which was spun down, washed
three times in PBS after which the cells were collected. Cells
(1 × 108/ml) were exposed to a concentration range of C5b6 or C5
and C6 in the presence of 100 nM C7. After washing, cells were
exposed to 20 nM C8 and 100 nM C9 for 30 min and spun down,
and absorbance of the supernatant at OD405 nm was measured.
Convertase labeling of bacteria
In all experiments, bacteria were grown overnight (o/n) in
Lysogeny broth (LB) medium (containing 50 lg/ml ampicillin for
PerimCherry/cytoGFP E. coli MG1655). Next day, subcultures were
grown to mid-log phase (OD660~0.5), washed and resuspended in
RPMI + 0.05% HSA. Unless stated differently, all incubations with
bacteria were performed in RPMI + 0.05% HSA. Bacteria with
OD660~0.1 were incubated with 10% C5 depleted serum (DC5 serum)
for 30 min at 37°C, washed and resuspended to OD660~0.05. Comple-
ment activation in DC5 serum was blocked by heat inactivation or by
adding 5 lM compstatin. For labeling with classical pathway conver-
tases, bacteria were incubated with DFB serum in the presence of
20 lg/ml OmCI for 30 min at 37°C. C5a generation was measured in
a calcium mobilization assay as previously described (Bestebroer
et al, 2010).
HAP1 cell lysis assay
DCD46/DCD55/DCD59 HAP1 cells (Thielen et al, 2018) were kindly
provided by Sanquin (Amsterdam, the Netherlands). Cells were
cultured in Iscove’s modified Dulbecco’s medium (IMDM) supple-
mented with 10% fetal bovine serum, penicillin, and streptomycin
(Gibco) at 37°C with 5% CO2. Cells were washed in PBS and
harvested using trypsin. The collected cells were washed 2 times in
PBS and resuspended to a concentration of 4 × 106 cells/ml in
VBS++. These cells were incubated with buffer (VBS++) or 25% C5
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depleted serum for 30 min at 37°C under shaking conditions. Unla-
beled or opsonized cells were washed twice in VBS++ (2 min at
300 g) after which 50 ll (100,000 cells/well) was incubated with
100 nM C5b6 or C5 and C6 in the presence of 100 nM C7, 10 lg/ml
FB, and 1 lg/ml FD for 15 min at 37°C. Cells were washed twice
and incubated with 100 nM C8 and C9 for 30 min at 37°C in the
presence of Sytox green. Cells were diluted 1:1 with PBS and Sytox
intensity was measured by flow cytometry.
Membrane permeabilization and bacterial viability assay
Unlabeled or convertase-labeled bacteria were prepared as
described above and incubated with 10% serum or purified MAC
components. Unless stated differently, 10 nM C5, 10 nM C6, 10 nM
C5b6, 20 nM C7, 20 nM C8, and 100 nM C9 were used. These
concentrations are similar to protein concentrations in 2–10%
serum. All incubations with serum and purified MAC components
were done for 30 min at 37°C. However, in experiments with
preassembled C5b6, a washing step was introduced to prevent fluid
phase MAC formation. Incubations with preassembled C5b6 were
done in the presence of C7 for 15 min at 37°C. Samples were
washed 3 times after which C8 and C9 were added for 30 min at
37°C. The washing step after C7 was also introduced when
uncleaved C5 and C6 were tested in the same experiment as
preassembled C5b6. For the C5b6 stability experiments, convertase-
labeled bacteria were incubated with C5 and C6 in the presence or
absence of C7 for 15 min at 37°C. Then, bacteria were washed or
incubated with RPMI or 10 lg/ml Eculizumab for another 15 min at
37°C. Subsequently, the remaining MAC components were added
for 30 min at 37°C, after which samples were diluted and measured
by flow cytometry. In all experiments, 2.5 lM Sytox Blue Dead Cell
Stain (Thermofisher) was added to the final incubation step of the
experiments. mCherry, Sytox, and GFP intensities were measured
by a MACSQuant flow cytometer.
Bacterial viability assay
After incubating bacteria with serum or purified MAC components
as described above, samples were serially diluted in PBS and
plated onto LB agar plates. Colonies were counted after overnight
incubation.
Complement deposition and trypsin treatment
Convertase-labeled bacteria were prepared as described above. To
measure C3b deposition, bacteria were incubated with 3 lg/ml
Alexa-488 labeled mouse-anti-C3b (described above) for 30 min at
4°C. C9 deposition was measured by C-terminal sortagging C9-
LPETG-His with GGG-N3, which was then coupled to Cy3-DBCO or
Cy5-DBCO. For trypsinization, bacteria were first incubated with
MAC components for 30 min and subsequently treated with 20 lg/
ml trypsin for 15 min at 37°C. C3b and C9 deposition was measured
by flow cytometry.
Confocal microscopy
Samples were prepared as described above, concentrated to
OD600~1.5, and dried onto 1% agar pads. To-pro-3 (1 lM,
Thermofisher) was used as a DNA dye. Agar pads were placed onto
a coverslip and samples were imaged using a Leica SP5 confocal
microscope with a HCX PL APO CS 63×/1.40–0.60 OIL objective
(Leica Microsystems, the Netherlands).
Structured illumination microscopy
8-well microslide (Ibidi) chambers were washed three times with
500 ll 1 M HCl/70% EtOH solution and rinsed with 500 ll MQ for
three times. Chambers were coated with 150 ll 1 M sodium
acetate/0.01 M NaOH and 4 ll Cell-Tak solution (Corning) for
20 min (RT), washed three times with MQ and dried. PerimCherry/
cytoGFP E. coli were grown to mid-log phase in the presence of 0.1%
arabinose, washed three times in MQ, and immobilized onto the
coverslip for 30 min. Samples were washed with RPMI + 0.05%
HSA, and images were obtained using the GE Healthcare Life-
Sciences “Deltavision OMXV4 blaze” microscope using 60× Olym-
pus lens (U-PLAN APO, NA 1.42) and immersion oil 1.516 (Cargille
laboratories). GFP and mCherry signals were measured using the
488-nm and 561-nm lasers, respectively, with suited dichroics and
emission filter setting of 528/48 and 609/37. Reconstructions and
registrations were performed using softWoRx (GE healthcare).
Atomic force microscopy
Mid-log phase bacteria (E. coli—MG1655/BL21) were washed three
times in PBS or PB (10 mM), concentrated four times, and immobi-
lized onto Cell-Tak or poly-L-lysine (0.01%) covered glass slides
(Corning/Sigma-Aldrich). Both methods of immobilization were
found to yield equivalent results. Care was taken not to allow the
bacteria to dry out during immobilization. Immobilized bacteria were
incubated with 10% DC5 serum in VBS++ containing 0.1% bovine
serum albumin (BSA) for 20 min at 37°C. Glass slides with immobi-
lized, serum-treated bacteria were rinsed 3 times with PBS/PB. Bacte-
ria were then treated with a solution of 25 lg/ml C5b6, 20 lg/ml C5,
12 lg/ml C6, 12 lg/ml C7, 50 lg/ml FB, and 5 lg/ml FD (all in
VBS++) and incubated for 5 min at RT. Following this, 15 lg/ml C8
and 70 lg/ml C9 in VBS++ were added for a 10–40 min incubation at
37°C. Glass slides with immobilized, treated bacteria were rinsed 3
times in PBS/PB before atomic force microscopy imaging.
Atomic force microscopy topographic images of E. coli (MG1655)
in Figs 8D and EV5 were obtained using a Nanowizard III AFM with
an UltraSpeed head (JPK, Germany) operated in liquid at room
temperature. The microscope was operated in intermittent contact
mode using FastScan-D probes (k = 0.25 N/m; Bruker). Images
were processed using Gwyddion (Necas & Klapetek, 2012) (http://
gwyddion.net/) for 1st order line-by-line flattening to remove tilt.
Images of bacterial surfaces were then processed using an additional
2nd order polynomial fit to remove the curvature of the bacteria.
The data on E. coli (BL21) shown in Fig 8C were obtained using a
Bruker FastScan Bio AFM, operated in PeakForce Tapping mode in
liquid at 8 kHz using FastScan-D probes (k = 0.25 N/m; Bruker).
Images were processed using NanoScope Analysis (Bruker) for 1st
order line-by-line flattening to remove tilt. Images of E. coli surfaces
were processed using an additional 2nd order polynomial fit to
remove the curvature of the bacteria and using a ~1.5 nm low-pass
filter to remove high frequency noise. Images are displayed as
height data in 3D. Cross-sectional analysis was performed in
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NanoScope Analysis and plotted in Origin (OriginLab), along the
dotted lines indicated in Fig 8C. For measurements of bacterial
height, the cross-sectional profile was taken over a 500 nm width to
obtain an average for the bacterium.
Data analysis and statistical testing
Flow cytometry data were analyzed in FlowJo, and percentage posi-
tive cells were based on gating for positive controls. Graphpad 6.0
was used for graph design and statistical analysis. Statistical analy-
sis was done using a ratio paired two-tailed t-test or a one-way
ANOVA as indicated in the figure legends, in which each condition
was compared with a control sample (buffer treated) unless stated
differently. Three experimental replicates were performed to allow
statistical analysis.
Expanded View for this article is available online.
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